Canada markets closed

Monte Rosa Therapeutics, Inc. (GLUE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.1600+0.1700 (+4.26%)
At close: 04:00PM EDT
4.1600 0.00 (0.00%)
After hours: 04:02PM EDT
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-101,159
-135,352
-108,501
-73,958
-35,879
-
Depreciation & amortization
3,484
6,222
3,745
2,132
537
-
Stock based compensation
10,194
16,669
11,664
5,200
354
-
Change in working capital
2,392
72,466
-2,134
6,286
4,255
-
Accounts Payable
3,841
5,758
-744
-706
3,435
-
Other working capital
-91,376
-62,843
-105,377
-69,095
-26,442
-
Other non-cash items
3,202
-
4,814
960
7,680
-276
Net cash provided by operating activites
-82,677
-43,802
-92,466
-59,363
-23,053
-
Cash flows from investing activities
Investments in property, plant and equipment
-8,699
-19,041
-12,911
-9,732
-3,389
-
Purchases of investments
-91,395
-103,151
-384,417
0
-
-
Sales/Maturities of investments
180,905
210,931
178,000
0
-
-
Net cash used for investing activites
-168,327
88,801
-219,219
-9,653
-3,389
-
Cash flows from financing activities
Common stock issued
0
0
20,055
237,750
0
-
Common stock repurchased
-
-
-
-
-440
0
Other financing activites
-452
-116
-364
-3,337
-440
-
Net cash used privided by (used for) financing activities
-103
27,492
20,466
377,562
60,060
-
Net change in cash
-251,107
72,491
-291,219
308,546
33,618
-
Cash at beginning of period
368,763
60,190
351,409
42,863
9,245
-
Cash at end of period
117,656
132,681
60,190
351,409
42,863
-
Free Cash Flow
Operating Cash Flow
-82,677
-43,802
-92,466
-59,363
-23,053
-
Capital Expenditure
-8,699
-19,041
-12,911
-9,732
-3,389
-
Free Cash Flow
-91,376
-62,843
-105,377
-69,095
-26,442
-